Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis
Download
Full text for this resource is not available from the Research Repository.
Export
Rodi, M, de Lastic, AL, Antonopoulou, S, Kylintireas, C, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Matsoukas, J and Mouzaki, A (2019) Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 33 (3). pp. 92-93. ISSN 1011-6583
Item type | Article |
URI | https://vuir.vu.edu.au/id/eprint/41133 |
Subjects | Historical > FOR Classification > 1107 Immunology Current > Division/Research > College of Health and Biomedicine |
Keywords | autoimmune disease; central nervous system; immunological tolerance; T cell tolerance |
Citations in Scopus | 0 - View on Scopus |
Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)